| Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases A Serafino, G Sferrazza, A Colini Baldeschi, G Nicotera, F Andreola, ... Expert Opinion on Drug Discovery 12 (2), 169-186, 2017 | 55 | 2017 |
| Brain aging: A Ianus‐faced player between health and neurodegeneration S Vanni, A Colini Baldeschi, M Zattoni, G Legname Journal of neuroscience research 98 (2), 299-311, 2020 | 49 | 2020 |
| Serpin signatures in prion and Alzheimer’s diseases M Zattoni, M Mearelli, S Vanni, A Colini Baldeschi, TH Tran, C Ferracin, ... Molecular neurobiology 59 (6), 3778-3799, 2022 | 30 | 2022 |
| Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson’s Disease via Up-regulation of the Wnt/β-Catenin Pathway A Colini Baldeschi, E Pittaluga, F Andreola, S Rossi, M Cozzolino, ... Frontiers in Aging Neuroscience 10, 20, 2018 | 17 | 2018 |
| Novel regulators of PrPC expression as potential therapeutic targets in prion diseases A Colini Baldeschi, S Vanni, M Zattoni, G Legname Expert Opinion on Therapeutic Targets 24 (8), 759-776, 2020 | 13 | 2020 |
| Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling D Giovannini, F Andreola, P Spitalieri, EK Krasnowska, A Colini Baldeschi, ... Cell Death Discovery 7 (1), 330, 2021 | 12 | 2021 |
| Innovative non-PrP-targeted drug strategy designed to enhance prion clearance A Colini Baldeschi, M Zattoni, S Vanni, L Nikolic, C Ferracin, G La Sala, ... Journal of medicinal chemistry 65 (13), 8998-9010, 2022 | 9 | 2022 |
| In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives L Zaccagnini, G Rossetti, TH Tran, G Salzano, A Gandini, AC Baldeschi, ... European journal of medicinal chemistry 196, 112295, 2020 | 9 | 2020 |
| iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation CA Tristán-Noguero A, Fernández-Carasa I, Calatayud C, Bermejo-Casadesús C ... EMBO Mol Med, 2023 | 5 | 2023 |
| Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models M Staderini, S Vanni, AC Baldeschi, G Giachin, M Zattoni, L Celauro, ... European Journal of Medicinal Chemistry 245, 114923, 2023 | 5 | 2023 |
| Tetrahydrobiopterin (BH4) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in … K Jung‐kc, A Tristán‐Noguero, A Altankhuyag, D Piñol Belenguer, ... Journal of Inherited Metabolic Disease 47 (3), 494-508, 2024 | 3 | 2024 |
| SERPINA3/SerpinA3n: a novel promising therapeutic target in prion diseases A Colini Baldeschi SISSA, 2021 | | 2021 |
